UncategorizedNew Releases from NCBI BookshelfBimekizumab for treating moderate to severe plaque psoriasis.Bimekizumab for treating moderate to severe plaque psoriasis. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfNivolumab with ipilimumab and chemotherapy for untreated metastatic non-small-cell lung cancer.Nivolumab with ipilimumab and chemotherapy for untreated metastatic non-small-cell lung cancer. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfMidostaurin for treating advanced systemic mastocytosis.Midostaurin for treating advanced systemic mastocytosis. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfDaratumumab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal).Daratumumab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal). Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfVericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal).Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal). Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfAbiraterone for treating newly diagnosed high-risk hormone-sensitive metastatic prostate cancer.Abiraterone for treating newly diagnosed high-risk hormone-sensitive metastatic prostate cancer. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfAbemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy.Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfPemigatinib for treating relapsed or refractor advanced cholangiocarcinoma with FGFR2 fusion or rearrangement.Pemigatinib for treating relapsed or refractor advanced cholangiocarcinoma with FGFR2 fusion or rearrangement. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfSapropterin for treating hyperphenylalaninaemia in phenylketonuria.Sapropterin for treating hyperphenylalaninaemia in phenylketonuria. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfBaloxavir marboxil for treating acute uncomplicated influenza (terminated appraisal).Baloxavir marboxil for treating acute uncomplicated influenza (terminated appraisal). Leave a Comment / Uncategorized / admin Post Content